Our Oct. list of news & research highlights MS – online fatigue management, positive phase III trials, vitamin D, & more.
We present a selection of interesting neurology articles for the month of October in the following slides. See the slide legends for links to the article summaries.
Gender Differences: a Lifetime Analysis of the Economic Burden of Alzheimer's Disease. Abstract link. **** Critical Role of Acetylation in Tau-Mediated Neurodegeneration and Cognitive Deficits. Abstract link.
Delivery of Epilepsy Care to Adults with Intellectual and Developmental Disabilities. Abstract link.**** Seizures as Adverse Events of Antibiotic Drugs. Abstract link.
New Investigator and Trainee Task Force Survey on the Recruitment and Retention of Headache Specialists. Abstract link.****Safety, Tolerability, and Efficacy of TEV-48125 for Preventive Treatment of High-Frequency Episodic Migraine: a Multicentre, Randomised, Double-Blind, Placebo-Controlled, Phase 2b Study. Abstract link.
Minocycline Reduces the Relative Risk of Multiple Sclerosis in People Experiencing Their First Clinical Demyelinating Event by 44.6%: Results of a Phase III Double-Blind Placebo Controlled Canadian Multicentre Clinical Trial. Abstract link. See Metz LM et al. Abstract 2359. ECTRIMS; Oct 10, 2015.**** Online Fatigue Management Program for Patients with Multiple Sclerosis - a Randomized Controlled Trial. Abstract link. See Poettgen J et al. Abstract 954. ECTRIMS; Oct 8, 2015.
Natalizumab in the Pediatric MS Population: Results of the Italian Registry. Abstract link.**** Genentech’s Ocrelizumab First Investigational Medicine to Show Positive Pivotal Study Results in Both Relapsing and Primary Progressive Forms of Multiple Sclerosis. Genentech press release. See also Montalban X et al. Abstract 2368. ECTRIMS; Oct 10, 2015. Abstract link.
Infection, Vaccination, and Childhood Arterial Ischemic Stroke. Abstract link. **** Alcohol Consumption Does Not Seem to Protect Against Stroke. Abstract link.